One other little gem from Alex:
“Our seed to GMP product business model for the B2B marketcontinues to resonate with a range of customers, and this has allowed the Company to unlock a numberof value accretive opportunities to underpin revenue growth. The sector is going through a shakeout andperiod of consolidation of which ECS is benefiting with onboarding of new customers.”
That to me is a clear nod from the industry towards low cost producers having the better business model.
Ann: Marketing, Operational & Revenue Update, page-14
Add ECS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.61M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.5¢ | $24.92K | 1.627M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 4145164 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 179948 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.6¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.5¢ | 1.6¢ | 1.5¢ | 2413157 | ||
| Last updated 15.57pm 14/06/2024 ? | |||||
| ECS (ASX) Chart |